Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
  • 9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
  • 8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib
  • 8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...
  • 8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China
  • 8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval
  • 8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...
  • 8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...
  • 8/26/2025Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...
  • 8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...
  • 8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China
  • 8/26/2025Pregene Secures Orphan Drug Status for Innovative Dual-Target CAR-T Th...
  • 8/26/2025CorrectSequence's CS-101: A Breakthru Base-Editing Therapy Cures First...
  • 8/26/2025Centergene's SJ02 Approved for Marketing, Advancing Assisted Reproduct...
  • 8/25/2025HemaCell Receives FDA IND Approval for Megakaryocyte Therapy
  • 8/25/2025Vivace Therapeutics Secures FDA Orphan Drug Designation for VT3989 in ...
  • 8/22/2025NMPA Approves AZ/Daiichi Sankyo's Datopotamab Deruxtecan
  • 8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance
  • 8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...
  • 8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children
  • 8/22/2025CARsgen's Satri-cel Becomes First CAR-T Therapy for Solid Tumors to Re...
  • 8/22/2025Kintor's KX-826 Tincture Nabs Triumph in Phase II Male AGA Trial
  • 8/21/2025Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...
  • 8/21/2025Zelgen Secures FDA IND Approval for Novel Trispecific Cancer Therapy
  • 8/21/2025Novartis' Vanrafia (atrasentan) Gains Regulatory Nod in China as Secon...
  • 8/21/2025Nicox Targets U.S. and China Filings After Second Phase III Win for NC...
  • 8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...
  • 8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success
  • 8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval
  • 8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...
  • Page:3/20 Total number of articles:583: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group